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CASE REPORT

Prosthetic rehabilitation of the geriatric oncologic rhinectomy
patient utilizing a craniofacial implant-retained nasal prosthesis
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Abstract
This clinical report describes the expeditious treatment of a geriatric patient with
squamous cell carcinoma of the nose treated with total rhinectomy, craniofacial implant placement, and a nasal prosthesis.
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IN TRO D U C T ION

Esthetic and functional rehabilitation of a geriatric patient
requiring rhinectomy presents challenges for both the patient
and the clinician. This clinical report describes the treatment
sequence and management considerations for a geriatric patient with squamous cell carcinoma of the nose treated with
total rhinectomy, craniofacial implant placement, and a nasal
prosthesis.
Malignancies involving the nasal vestibule are rare and
comprise 1% of all head and neck squamous cell carcinomas.1 Treatment for nasal squamous cell carcinoma may include ablative surgery with or without adjuvant therapy. The
decision of how to restore the resulting facial defect, either
surgically or prosthetically, is often determined by a combination of patient and physician factors.
Surgical reconstruction may not be a simple task depending upon the size of the defect and may require multiple

surgeries to obtain an acceptable result. Total treatment
time may vary; however, completion of surgical nasal reconstruction has been reported to be upward of 26 months.2
Additionally, surgical reconstruction may have esthetic limitations in the ability to match the color and contour of the
reconstructed nose compared to the preoperative appearance.
For elderly or medically compromised patients that are poor
candidates for prolonged treatment courses that are likely
to require multiple surgeries, alternative treatment options
should be considered.
As an alternative, reconstruction of a nasal defect with
a prosthesis is expeditious and can faithfully replicate the
missing facial structure.3 Conventional nasal prosthesis
fabrication can be completed when the surgical bed is wellhealed, and the completed prosthesis is retained by medical grade adhesive. The interval for adhesive reapplication
on the prosthesis is patient-specific. Additionally, patients
are required to clean the adhesive from their prosthesis and
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their skin on a daily basis. This may be challenging for a
geriatric or nondexterous patient, and the patient may require additional assistance. To alleviate these challenges,
craniofacial implants can be utilized to retain the nasal
prosthesis.
Craniofacial implants, often fabricated in titanium, are a
reliable technique for maxillofacial reconstruction with reported implant success rates of 70%-80%.4-6 The location of
the craniofacial implant has been reported to impact success
with nasal implant success ranging from 71.4% to 100%,2,7,8
and orbital implant success ranging from 27% (irradiated
implant sites) to 75% (nonradiated implant sites).2,8,9 Dental
implants have been reported to be successful in geriatric patients10 but there are limited reports on the role of craniofacial implants in a geriatric oncologic population. The purpose
of the study is to describe the process for management of a
geriatric patient with squamous cell carcinoma of the nose
reconstructed with a treatment workflow utilizing craniofacial implants.
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CA S E RE P O RT

An 86-year-old female patient presented to the Head and
Neck Service at Memorial Sloan Kettering Cancer Center
for management of a locally advanced squamous cell carcinoma of the left nose (Figure 1A,B). The patient was
recommended to have a total rhinectomy with bilateral
modified neck dissection with reconstruction of the nasal
defect with a nasal prosthesis. The oncological resection was carried out by the head and neck surgical team.
Subsequent pathology showed an advanced primary cancer with clear surgical margins and with no pathological

(A)

F I G U R E 1 A, Frontal view of
preoperative view of the squamous cell
carcinoma of the nose. B, Lateral view of
preoperative view of the squamous cell
carcinoma of the nose
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involved lymph nodes. As such, no postoperative radiation
was recommended. After a discussion of the risks and benefits of treatment, including the course of treatment for surgical and/or prosthetic reconstruction, the patient elected to
have her planned nasal defect prosthetically reconstructed.
The patient was preoperatively evaluated by the Dental
Service, and a nasal moulage was made. The patient was
then planned for craniofacial implants to facilitate retention of the nasal prosthesis.
Total rhinectomy with bilateral modified neck dissection
was performed by the head and neck team. A provisional
nasal prosthesis11 was delivered postoperatively which replicated the patient's nasal contours. The prosthesis was secured
with three pieces of medical grade adhesive tape and was removed daily by the patient.
A postoperative CBCT was completed for craniofacial implant planning. A nasal surgical stent was fabricated to assist
in the accurate placement of the craniofacial implants based
on the surgical plan. The patient was then brought back to the
operating room 2 weeks following rhinectomy for placement
of the craniofacial implants. The surgical stent was utilized to
identify the planned implant locations intraoperatively. An incision was made on the nasal floor exposing the premaxilla
and vertically along the glabellar skin to expose the bone in
the glabellar region. Three osteotomies were created, two in
the premaxilla region and one in the glabellar region, and three
4 mm craniofacial implants (Vistafix VXI300; Cochlear) were
then placed to the proper depth with adequate primary stability. Three sterile cover screws were placed on the implants and
were hand-tightened (Figure 2). Primary closure was achieved
with 3-0 vicryl sutures on the nasal floor and 5-0 nylon sutures in the glabellar region. Xeroform packing was placed
within the nasal cavity. The patient was counseled to return

(B)
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FIGURE 2

CT showing the three implants placed for prosthetic
replacement support

for follow-up in 2-3 months to begin fabrication of a definitive
nasal prosthesis.
The patient returned to the Dental Service 3 months status
postsurgery for uncovery of the craniofacial implants. Topical
betadine was administered to the skin surrounding the nasal defect, and local anesthesia (68 mg 2% lidocaine with 1:100 000
epinephrine) was directly administered to the skin surrounding
the implant sites. The implant in the glabellar region did not require tissue excision as the implant platform was exposed. The
cover screw of the superior implant was removed, and a 7.5 mm
sterile healing abutment was placed and hand-tightened. Then,
two soft tissue punches were completed using a 4 mm-tissue
punch, exposing the two implants in the premaxilla area and two
sterile 7.5 mm healing abutments were placed and hand-tightened. Xeroform gauze was used around the abutments in the
premaxilla to compress the adjacent skin, and the patient was
counseled to use bacitracin for postoperative wound care.
After 1 month, the patient returned to begin fabrication of the nasal prosthesis. A nasal moulage was completed using irreversible hydrocolloid impression material
(Jeltrate Plus; Dentsply Sirona) and fast setting plaster
(Type V, Diekeen green; Kulzer Dental). Then, the healing
abutments were removed and replaced with 7.5 mm final
abutments (Vistafix VXA300; Cochlear) and were torqued
to 25 Ncm. Three prosthesis magnets were placed: one
on the abutment in the glabellar region (Maxilip magnet;
Factor II Inc) and 2 on the abutments in the premaxilla region (Minilip magnet; Factor II Inc) (Figure 3). Magnetic
impression copings (S-range, Factor II Inc) that had
been luted together with acrylic resin (Jet, Lang Dental
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F I G U R E 3 Frontal view showing postoperative complete
healing postimplant placement

Manufacturing Co., Inc) were used to complete another facial moulage with irreversible hydrocolloid (Jeltrate Plus;
Dentsply Sirona) and fast setting plaster (Type V, Diekeen
green; Kulzer Dental) to transfer the implant locations
onto a model of the patient.
Using the patient's model, a wax sculpture of the nasal
prosthesis was then made and was subsequently tried on
the patient. A custom magnetic keeper (S-range, Factor II
Inc) was tried on the magnetic abutments and was properly
adapted. A base shade for the nasal prosthesis was selected
followed by processing of the prosthesis into silicone (RTV
40, Factor II Inc) which was extrinsically tinted to match the
patient's adjacent skin colors. The completed nasal prosthesis was then delivered (total treatment time 8 months following surgery) (Figure 4A,B), and home care instructions
were reviewed. The patient and family were very satisfied
with the esthetics, fit, and function of the nasal prosthesis.
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DISCUSSION

Acquired nasal defects are debilitating deformities that require preplanning for adequate reconstruction. For the geriatric patient, the use of adjuvant therapy, the risk of disease
recurrence, systemic comorbidities, and known complications of general anesthesia may diminish enthusiasm
from a conventional approach for surgical reconstruction.
Moreover, a reconstructive plan requiring multiple surgeries and prolonged treatment time may be undesirable for
this patient population. To optimize outcomes, inclusion
of supportive care team members (ie, including nursing,
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F I G U R E 4 A, Frontal postoperative
view with the nasal prosthesis in place. B,
Lateral postoperative view with the nasal
prosthesis in place

counseling, and social work) has previously been previously reported.12-14
Prosthetic rehabilitation of a nasal defect is an alternative option for geriatric patients which does not require additional surgery, is safe, and has a shorter treatment time.
Additionally, the use of craniofacial implants is desirable for
this patient population to assist in prosthesis retention. As
in this report, a magnet retention system may assist a geriatric patient in positioning the prosthesis during prosthesis
placement. The use of a medical grade adhesive can be completely avoided which may be desirable for a nondexterous
patient. Home hygiene of the implant abutments is required;
however, localized implant dermatitis/mucositis (3%-60%
depending on the severity of the reaction)7,15 is the most
commonly described biologic complication. Management is
usually limited to local control with tissue excision.3
If the outlined approach is being considered for a geriatric patient undergoing oncologic resection, primary placement of craniofacial implants during the primary oncologic
surgery is desirable. This eliminates the need for additional
surgeries for implant placement as well as minimizes overall treatment time. Moreover, a multidisciplinary treatment
team inclusive of supportive and rehabilitation medicine
specialists is a prerequisite for successful execution of oncologic resection, implant planning and placement, and
prosthetic fabrication.
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CO NC LU SION

For an oncologic aging patient unable or unwilling to undergo
surgical reconstruction of a nasal defect posttotal rhinectomy,

prosthetic rehabilitation with craniofacial implants offers an
expeditious reconstructive approach. Multidisciplinary care
is needed for a satisfactory outcome.
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